Skip to main content
. 2017 Jun 21;8(38):63038–63046. doi: 10.18632/oncotarget.18593

Figure 4. Elevated YKL-40 and reduced miR-24 identified in DM2-CHD, CHD, and control.

Figure 4

Correlation between circulating miR-24 and plasma YKL-40 in DM2-CHD (A), CHD (B), and controls (C), respectively.